These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23098072)

  • 61. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.
    Chowdhury P; Sacks SH; Sheerin NS
    Clin Exp Immunol; 2006 Aug; 145(2):346-56. PubMed ID: 16879256
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blocking NF-κB Is Essential for the Immunotherapeutic Effect of Recombinant IL18 in Pancreatic Cancer.
    Guo X; Zheng L; Jiang J; Zhao Y; Wang X; Shen M; Zhu F; Tian R; Shi C; Xu M; Li X; Peng F; Zhang H; Feng Y; Xie Y; Xu X; Jia W; He R; Xie C; Hu J; Ye D; Wang M; Qin R
    Clin Cancer Res; 2016 Dec; 22(23):5939-5950. PubMed ID: 27297583
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
    Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
    J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide.
    Shen KY; Song YC; Chen IH; Chong P; Liu SJ
    Hum Vaccin Immunother; 2014; 10(11):3241-50. PubMed ID: 25483652
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor-released autophagosomes induces CD4
    Chen YQ; Li PC; Pan N; Gao R; Wen ZF; Zhang TY; Huang F; Wu FY; Ou XL; Zhang JP; Zhu XJ; Hu HM; Chen K; Cai YL; Wang LX
    J Immunother Cancer; 2019 Jul; 7(1):178. PubMed ID: 31300052
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TLR2 regulates allergic airway inflammation through NF-κB and MAPK signaling pathways in asthmatic mice.
    Ma SQ; Wei HL; Zhang X
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3138-3146. PubMed ID: 29863259
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of CD44 in Regulating TLR2 Activation of Human Macrophages and Downstream Expression of Proinflammatory Cytokines.
    Qadri M; Almadani S; Jay GD; Elsaid KA
    J Immunol; 2018 Jan; 200(2):758-767. PubMed ID: 29196459
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.
    Garay RP; Viens P; Bauer J; Normier G; Bardou M; Jeannin JF; Chiavaroli C
    Eur J Pharmacol; 2007 Jun; 563(1-3):1-17. PubMed ID: 17383632
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors.
    Means TK; Lien E; Yoshimura A; Wang S; Golenbock DT; Fenton MJ
    J Immunol; 1999 Dec; 163(12):6748-55. PubMed ID: 10586073
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.
    Macedo AB; Novis CL; De Assis CM; Sorensen ES; Moszczynski P; Huang SH; Ren Y; Spivak AM; Jones RB; Planelles V; Bosque A
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282829
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Essential role of Toll-like receptor 2 in macrophage activation by glycogen.
    Kakutani R; Adachi Y; Takata H; Kuriki T; Ohno N
    Glycobiology; 2012 Jan; 22(1):146-59. PubMed ID: 21873606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors.
    Schölch S; Rauber C; Tietz A; Rahbari NN; Bork U; Schmidt T; Kahlert C; Haberkorn U; Tomai MA; Lipson KE; Carretero R; Weitz J; Koch M; Huber PE
    Oncotarget; 2015 Mar; 6(7):4663-76. PubMed ID: 25609199
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice.
    Zhang Y; Luo F; Li A; Qian J; Yao Z; Feng X; Chu Y
    Clin Immunol; 2014 Sep; 154(1):26-36. PubMed ID: 24928324
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin.
    Kong X; Wu SH; Zhang L; Chen XQ
    Mol Med Rep; 2015 Jul; 12(1):895-904. PubMed ID: 25760938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis.
    Janeckova L; Pospichalova V; Fafilek B; Vojtechova M; Tureckova J; Dobes J; Dubuissez M; Leprince D; Baloghova N; Horazna M; Hlavata A; Stancikova J; Sloncova E; Galuskova K; Strnad H; Korinek V
    Mol Cancer Res; 2015 Jul; 13(7):1139-48. PubMed ID: 25934696
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
    Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
    J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.
    Assudani D; Cho HI; DeVito N; Bradley N; Celis E
    Cancer Res; 2008 Dec; 68(23):9892-9. PubMed ID: 19047170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam
    Du X; Qian J; Wang Y; Zhang M; Chu Y; Li Y
    Bioorg Med Chem; 2019 Jul; 27(13):2784-2800. PubMed ID: 31101493
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.
    Huang ZM; Kang JK; Chen CY; Tseng TH; Chang CW; Chang YC; Tai SK; Hsieh SL; Leu CM
    J Immunol; 2012 Jun; 188(12):5867-76. PubMed ID: 22581854
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue.
    Vitseva OI; Tanriverdi K; Tchkonia TT; Kirkland JL; McDonnell ME; Apovian CM; Freedman J; Gokce N
    Obesity (Silver Spring); 2008 May; 16(5):932-7. PubMed ID: 18292749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.